Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do Multiple Drug Resistance Transporters Interfere with Cell Functioning under Normal Conditions?

D A Knorre1,2, K V Galkina3, T Shirokovskikh4

  • 1Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia. knorre@belozersky.msu.ru.

Biochemistry. Biokhimiia
|March 11, 2021
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First crystallographic signature of amyloid-like fibril forming beta-sheet assemblage from a tripeptide with non-coded amino acids.

Chemical communications (Cambridge, England)·2002
Same author

Audit of stapedectomy results in a district general hospital.

Clinical otolaryngology and allied sciences·2002
Same author

Coronary artery disease and its problems in management.

Journal of the Indian Medical Association·2002
Same author

Leucopenia in adult polycystic kidney disease patients on haemodialysis.

Nephron·2002
Same author

Traditional healers and their practices in Malawi.

Tropical doctor·2002
Same author

Enhanced frequency of micronuclei in individuals exposed to arsenic through drinking water in West Bengal, India.

Mutation research·2002
Same journal

Multidirectional Effects of SARS-CoV-2 Coronavirus Proteins on Amyloid Transformation of Alpha-Synuclein.

Biochemistry. Biokhimiia·2026
Same journal

Dependence of Antioxidant and Transcriptional Responses to Periodic Hypoxia on Sex and Age in Rats.

Biochemistry. Biokhimiia·2026
Same journal

Effect of the PPARγ Agonist Pioglitazone on Rat Behavior and Expression of Epileptogenesis-Related Genes during the Latent Phase of the Lithium-Pilocarpine Model.

Biochemistry. Biokhimiia·2026
Same journal

A Conjugate of Aminoadamantane and Tetrahydro-γ-Carboline Inhibits Accumulation of Mutant α-Synuclein A53T in the Cellular Model of Proteinopathy.

Biochemistry. Biokhimiia·2026
Same journal

Immunoinflammatory Markers in Patients with Affective Disorders: Genetic Polymorphisms, Peripheral Cytokine Levels, and Expression of IL-1β, IL-13, TNF-β, and TGF-α in Peripheral Blood Mononuclear Cells.

Biochemistry. Biokhimiia·2026
Same journal

Method for Individual Assessment of Human Cerebral Cortex Activity by a Combined Use of Magnetic Resonance Spectroscopy of Glutamate and BOLD Signal Method.

Biochemistry. Biokhimiia·2026
See all related articles
This summary is machine-generated.

Eukaryotic cells use drug-efflux transporters to combat toxins, but these systems can have unintended costs. Understanding these limitations may help overcome drug resistance in fungi.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Microbiology

Background:

  • Eukaryotic cells possess defense mechanisms against toxic compounds, including plasma membrane transporters conferring multiple drug resistance (MDR).
  • These MDR transporters, such as ATP-binding cassette (ABC) and major facilitator superfamily (MFS) transporters, efflux xenobiotics using cellular energy.
  • This review examines the potential drawbacks of active drug-efflux systems, using yeast as a model.

Purpose of the Study:

  • To discuss the potential costs associated with active drug-efflux systems in eukaryotic cells.
  • To explore how the inherent properties of MDR transporters can negatively impact cellular functions.
  • To propose strategies for counteracting multidrug resistance by exploiting the limitations of these efflux systems.

Main Methods:

Related Experiment Videos

  • Review of existing literature on MDR transporters, focusing on yeast models.
  • Analysis of the biochemical and cellular consequences of MDR transporter activity.
  • Speculative analysis of therapeutic strategies targeting MDR.

Main Results:

  • Pleiotropic drug resistance (PDR) subfamily ABC-transporters consume ATP constitutively.
  • MDR transporters can possess flippase activity, potentially disrupting plasma membrane integrity.
  • Excessive transporter activity may lead to unintended efflux of essential metabolites and interfere with cell-to-cell communication.

Conclusions:

  • Active drug-efflux systems, while protective, incur significant cellular costs.
  • Overactivity of MDR transporters can compromise cell membrane properties and disrupt cellular processes.
  • Targeting the limitations of drug-efflux mechanisms presents a promising avenue for combating multidrug resistance, particularly in pathogenic fungi.